Factors associated with engaging socially marginalized HIV-positive persons in primary care

AIDS Patient Care and STDs

Volumn 21, Issue SUPPL. 1, 2007, Pages

  Rumptz, Maureen H ^a   Tobias, Carol ^b   Rajabiun, Serena ^b   Bradford, Judith ^c,d   Cabral, Howard ^b   Young, Robin ^b   Cunningham, William E ^e  

^a MULTNOMAH COUNTY HEALTH DEPARTMENT   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d FENWAY INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DEMOGRAPHY; DRUG ABUSE; FEMALE; FOLLOW UP; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; MULTIVARIATE ANALYSIS; PRIMARY MEDICAL CARE; SOCIAL ASPECT;

ADULT; COMMUNITY-INSTITUTIONAL RELATIONS; DEMOGRAPHY; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HEALTH STATUS; HIV INFECTIONS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY HEALTH CARE; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION;

EID: 34250840567     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2007.9989     Document Type: Article

References (20)

1. Berg MB, Safren SA, Mimiaga MJ, Grasso C, Boswell S, Mayer KH. Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care 2005;17:902-907.
2. Maher K, Klimas N, Fletcher MA, et al. Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an urban Veterans Affairs Medical center. J Acquir Immune Defic Syndr 1999;22:358-363.
3. Fleming P, Byers R, Sweeney P, Daniels D, Karon J, Janssen R. HIV Prevalence in the United States, 2000. Seattle, WA: 2002.
4. Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004;39:609-629.
5. Shapiro MF, Morton SC, McCaffrey DF et al. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2305-2315.
6. Giordano TP, White AC, Jr, Sajja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr 2003;32:399-405.
7. Arno PS, Bonuck KA, Green J, et al. The impact of housing status on health care utilization among persons with HIV disease. J Health Care Poor Underserved 1996;7:36-49.
8. Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization. J Acquir Immune Defic Syndr 2000;25:115-123.
9. Tobias C, Cunningham W, Cabral H, et al. Living with HIV but without medical care: Barriers to entry. AIDS Patient Care STDs 2007 (in press).
10. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2005. Available at: www.cdc.gov/hiv/stats/ hasrlink.htm (Last accessed March 27, 2007).
11. Cunningham WE, Andersen RM, Katz MH, et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care 1999;37:1270-1281.
12. Knowlton AR, Hoover DR, Chung SE, Celentano DD, Vlahov D, Latkin CA. Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug Alcohol Depend 2001;64:55-62.
13. Institute of Medicine. Access to Health Care in America. Washington, D.C.: National Academy Press, 1993.
14. Tobias C, Cunningham WE, Cunningham CO, Pounds MB. Making the connection: The imporance of engagement and retention in HIV medical care. AIDS Patient Care STDs 2007;21(Suppl 1):S-3-S-8.
15. Andersen R, Bozzette S, Shapiro M, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res 2000;35:389-416.
16. Rajabiun S, Mallinson R, McCoy K, et al. ©Getting me back on track©: The role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care STDS 2007; 21(Suppl 1):S-20-S-29.
17. Health and Disability Working Group. SPNS Outreach Initiative Program Descriptions. [Boston University School of Public Health website]. 2006. www.hdwg. org/core.html (Last accessed March 27, 2007).
18. Rajabiun S, Rebholz C, Tobias C, et al. Making the connection: Promoting engagement and retention in HIV medical care among hard-to-reach populations. Rockvill, MD: Health Resources and Services Administration, 2006.
19. McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:199-213.
20. Mancl LA, DeRouen TA. A covariance estimator for GEE with improved small-sample properties. Biometrics 2001;57:126-134.